Browse > Article
http://dx.doi.org/10.13160/ricns.2014.7.2.79

A Mini Review on Aβ Oligomers and its Pathogencity  

Tuyet, Pham Thi Dieu (Department of Biotechnology, Hanoi University of Science and Technology, University of Hanoi)
Publication Information
Journal of Integrative Natural Science / v.7, no.2, 2014 , pp. 79-86 More about this Journal
Abstract
Amyloid oligomers are believed to play important causal roles in many types of amyloid-related degenerative diseases. Many different laboratories have reported amyloid oligomers that differ in size, morphology, toxicity, and method of preparation or purification, raising the question of the structural relationships among these oligomer preparations. The structural plasticity that has been reported to occur in amyloid formed from the same protein sequence indicates that it is quite possible that different oligomer preparations may represent distinct structural variants. In view of the difficulty in determining the precise structure of amyloids, conformation- and epitope-specific antibodies may provide a facile means of classifying amyloid oligomer structures. Conformation-dependent antibodies that recognize generic epitopes that are specifically associated with distinct aggregation states of many different amyloid-forming sequences indicate that there are at least two fundamentally distinct types of amyloid oligomers: fibrillar and prefibrillar oligomers. Classification of amyloid oligomers according to their underlying structures may be a more useful and rational approach than relying on differences in size and morphology.
Keywords
$A{\beta}$; Monomers; Fibrils; Oligomers; Alzheimer's Disease;
Citations & Related Records
연도 인용수 순위
  • Reference
1 D. M. Walsh, I. Klyubin, J. V. Fadeeva, W. K. Cullen, R. Anwyl, M. S. Wolfe, M. J. Rowan, and D. J. Selkoe, "Intracerebroventricular administration of amyloid $\beta$-protein oligomers selectively increases dorsal hippocampal dialysate glutamate levels in the awake rat", Nature, Vol. 416, pp. 535-539, 2002.   DOI   ScienceOn
2 P. Picone, R. Carrotta, G. Montana, M. R. Nobile, P. L. S. Biagio, and M. Di Carlo, "A$\beta$ oligomers and fibrillar aggregates induce different apoptotic pathways in LAN5 neuroblastoma cell cultures", Biophysical J., Vol. 96, pp. 4200-4211, 2008.
3 C. M. Troy, S. A. Rabacchi, W. J. Friedman, T. F. Frappier, K. Brown, and M.L. Shelanski, "Caspase-2 mediates neuronal cell death induced by $\beta$-amyloid", J Neurosci., Vol. 20, pp. 1386-1392, 2000.
4 J. Harada and M. Sugimoto, "Activation of caspase-3 in $\beta$-amyloid induced apoptosis of cultured rat cortical neurons", Brain Res., Vol. 842, pp. 311-323, 1999.   DOI   ScienceOn
5 I. Klyubin, D. M. Walsh, C. A. Lemere, W. K. Cullen, G. M. Shankar, C. Betts, E. T. Spooner, K. Jiang, R. Anwyl, D. J. Selkoe, and M. J. Rowan, "Movement disorders: Neurodevelopment and neurobehavioural expression", Nat. Med., Vol. 11, pp. 556-561, 2005.   DOI
6 C. S. Goldsbury, G. J. Cooper, K. N. Goldie, S. A. Muller, E.L. Saafi, W.T. Gruijters, M.P. Misur, A. Engel, U. Aebi, and J. Kistler, "Polymorphic fibrillar assembly of human amylin", J. Struct. Biol., Vol. 119, pp. 17-27, 1997.   DOI
7 P. L. Whitney and C. Tanford, "Solubility of amino acids in aqueous urea solutions and its implications for the denaturation of proteins by urea", J. Biol. Chem., Vol. 237, pp. 1735-1737, 1962.
8 C. Hyde, T. Johnson, D. Owen, M. Quibell, and R.C. Sheppard, "Some 'difficult sequences' made easy. A study of interchain association in solidphase peptide synthesis", Int. J. Pept. Protein Res., Vol. 43, pp. 431-440, 1994.
9 R. T. Baker, A. M. Catanzariti, Y. Karunasekara, T.A. Soboleva, R. Sharwood, S. Whitney, and P.G. Board, "Using deubiquitylating enzymes as research tools", Methods Enzymol., Vol. 398, pp. 540-554, 2005.   DOI   ScienceOn
10 R. J. Jenny, K. G. Mann, and R. L. Lundblad, "A critical review of the methods for cleavage of fusion proteins with thrombin and factor Xa", Protein Expr. Purif., Vol. 31, pp. 1-11, 2003.   DOI   ScienceOn
11 P. A. Nygren, S. Stahl, and M. Uhlen, "Engineering proteins to facilitate bioprocessing", Trends Biotechnol., Vol. 12, pp. 184-188, 1994.   DOI   ScienceOn
12 A. K. Tickler, C. J. Barrow, and J. D. Wade, "Improved preparation of amyloid-beta peptides using DBU as Nalpha-Fmoc deprotection reagent", J. Pept. Sci., Vol. 7, pp. 488-494, 2001.   DOI
13 D. J. Seloke, "Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease", Annu. Rev. Cell Biol., Vol. 10, pp. 373-403, 1994.   DOI   ScienceOn
14 D. T. Loo, A. Copani, C. J. Pike, E. R. Whittemore, A. J. Walencewicz, and C. W. Cotman, "Apoptosis is induced by $\beta$-amyloid in cultured central nervous system neurons", Proc. Natl. Acad. Sci. USA, Vol. 90, pp. 7951-7955, 1993.   DOI   ScienceOn
15 K. J. Ivins and E. T. N. Bui, "Cotman CW. $\beta$-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis", Neurobiol. Dis. Vol. 5, pp. 365-378, 1998.   DOI   ScienceOn
16 C. Stadelmann, W. Bruck, C. Bancher, K. Jellinger, and H. Lassmann, "Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis", J. Neuropathol. Exp. Neurol., Vol. 57, pp. 456-464, 1998.   DOI   ScienceOn
17 T. Pillot, B. Drouet, S. Queille, C. Labeur, J. Vandekerckhove, M. Rosseneu, M. Pincon-Raymond, and J. Chambaz, "The nonfibrillar amyloid peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain", J. Neurochem., Vol. 73, pp. 1626-1634, 1999.
18 N. K. Robakis, N. Ramakrishna, G. Wolfe, and H.M. Wisniewski, "Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides", Proc. Natl. Acad. Sci. USA, Vol. 84, pp. 4190-4194, 1987.   DOI   ScienceOn
19 B. Solomon, R. Koppel, D. Frankel, and E. Hanan- Aharon, "Disaggregation of Alzheimer beta-amyloid by site-directed mAb", Proc. Natl. Acad. Sci. USA, Vol. 94, pp. 4109-4112, 1997.   DOI
20 Y. Su, C. L. Chang, S. S. Lee, W. C. Chen, and C. F. Huang, "In vitro cytotoxic activity of 1- decarboxy-3-oxo-ceanothic acid in a human ovarian adenocarcinoma cell line", Res. Commun. Mol. Pathol. Pharmacol., Vol. 100, pp. 313-326, 1998.
21 R. Vassar, B. D. Bennett, S. Babu-Khan, S. Kahn, E. A. Mendiaz, P. Denis, D. B. Teplow, S. Ross, P. Amarante, R. Loeloff, Y. Luo, S. Fisher, J. Fuller, S. Edenson, J. Lile, M.A. Jarosinski, A.L. Biere, E. Curran, T. Burgess, J. C. Louis, F. Collins, J. Treanor, G. Rogers, and M. Citron, "beta-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE", Science, Vol. 286, pp. 735-741, 1999.   DOI   ScienceOn
22 M. S. Wolfe, W. Xia, B. L. Ostaszewski, T. S. Diehl, W.T. Kimberly, and D. J. Selkoe, "Two transmembrane aspartates in presenilin-1 required for presenilin endoproteo-lysis and gamma-secretase activity", Nature, Vol. 398, pp. 513-517, 1999.   DOI
23 S. J. Wood, B. Maleeff, T. Hart, and R. Wetzel, "Physical morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Ab", J. Mol. Biol., Vol. 256, pp. 870-877, 1996.   DOI   ScienceOn
24 T. Yamazaki, E. H. Koo, and D. J. Selkoe, "Trafficking of cell-surface amyloid beta-protein precursor. II. Endocytosis, recycling and lysosomal targeting detected by immunolocalization", J. Cell Sci., Vol. 109, pp. 999-1008, 1996.
25 M. D. Kane, R. D. Schwarz, L. S. Pierre, M. D. Watson, M. R. Emmerling, P. A. Boxer, and G. K. Walker, "Inhibitors of V-Type ATPases, bafilomycin A1 and concanamycin A, protect against amyloidmediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet-razolium bromide (MTT) reduction", J. Neurochem., Vol. 72, pp. 1939-1947, 1999.
26 E. H. Koo and S. L. Squazzo, "Evidence that production and release of amyloid beta-protein involves the endocytic pathway", J. Biol. Chem., Vol. 269, pp. 17386-17389, 1994.
27 D. Burdick, B. Soreghan, M. Kwon, J. Kosmoski, M. Knauer, A. Henschen, J. Yates, C. Cotman, and C. Glabe, "Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs", J. Biol. Chem., Vol. 267, pp. 546-554, 1992.
28 P. T. Chang and Y. Su, "Protocol for qualitative analysis of the in vitro aggregation of synthetic beta-amyloid: A method applicable to the identification of substances that may have therapeutic efficacy for Alzheimer's disease", Brain Res. Protoc., Vol. 6, pp. 6-12, 2000.   DOI
29 L. Giovannelli, C. Scali, M.S. Faussone-Pellegrini, G. Pepeu, and F. Casamenti, "Long-term changes in the aggregation state and toxic effects of betaamyloid injected into the rat brain", Neuroscience, Vol. 87, pp. 349-357, 1998.   DOI
30 M.P. Lambert, A.K. Barlow, B.A. Chromy, C. Edwards, R. Freed, M. Liosatos, T.E. Morgan, I. Rozovsky, B. Trommer, K.L. Viola, P. Wals, C. Zhang, C.E. Finch, G.A. Krafft, and W.L. Klein, "Diffusible, nonfibrillar ligands derived from Ab1-42 are potent central nervous system neurotoxins", Proc. Natl. Acad. Sci. USA, Vol. 95, pp. 6448-6453, 1998.   DOI   ScienceOn
31 G.A. MacGibbon, G.J. Cooper, and M. Dragunow, "Acute application of human amylin, unlike betaamyloid peptides, kills undifferentiated PC12 cells by apoptosis", NeuroReport, Vol. 8, pp. 3945-3950, 1997.   DOI
32 M.M. Pallitto, J. Ghanta, P. Heinzelman, L.L. Kiessling, and R.M. Murphy, "Recognition sequence design for peptidyl modulators of bamyloid aggregation and toxicity", Biochemistry, Vol. 38, pp. 3570-3578, 1999.   DOI   ScienceOn
33 W. Garzon-Rodriguez, M. Sepulveda-Becerra, S. Milton, and C. G. Glabe, "Amyloid ${\beta}$-peptide polymerization studied using fluorescence correlation spectroscopy", J. Biol. Chem., Vol. 272, pp. 21037-21044, 1997.   DOI
34 A. J. Patel, S. Gunasekera, A. Jen, and H. A. R de Silva, "b-Amyloid-mediated inhibition of redox activity (MTT reduction) is not an indicator of astroglial degeneration", NeuroReport, Vol. 7, pp. 2026-2030, 1996.   DOI
35 C. J. Pike, A. J. Walencewicz, C. G. Glabe, and C. W. Cotman, "In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity", Brain Res., Vol. 563, pp. 311-314, 1991.   DOI
36 B. Soreghan, J. Kosmoski, and C. Glabe, "Observation of metastable $A{\beta}$ amyloid protofibrils by atomic force microscopy", J. Biol. Chem., Vol. 269, pp. 28551-28554, 1994.
37 D. M. Walsh, A. Lomakin, G. B. Benedek, M. M. Condron, and D. B. Teplow, "Amyloid ${\beta}$-protein fibrillogenesisstructure and biological activity of protofibrillar intermediates", J. Biol. Chem., Vol. 272, pp. 22364-22372, 1997.   DOI   ScienceOn
38 H. A. Lashuel, D. Hartley, B. M. Petre, T. Walz, and P. T. Lansbury, Jr, "Dissociation of amyloid fibrils of $\alpha$-synuclein and transthyretin by pressure reveals their reversible nature and the formation of waterexcluded cavities", Nature, Vol. 418, pp. 291, 2002.
39 M. Anguiano, R. J. Nowak, and P. T. Lansbury, Jr, "Membrane interaction of islet amyloid polypeptide", Biochemmistry, Vol. 41, pp. 11338-11343, 2002.   DOI
40 A. Lomakin, D.B. Teplow, D. A. Kirschner, and G. B. Benedek, "Kinetic theory of fibrillogenesis of amyloid$\beta$-protein", Proc. Natl. Acad. Sci. USA, Vol. 94, pp. 7942-7947, 1997.   DOI
41 S. Barghorn, V. Nimmrich, A. Striebinger, C. Krantz, P. Keller, B. Janson, M. Bahr, M. Schmidt, R. S. Bitner, J. Harlan, E. Barlow, U. Ebert, and H. Hillen, "Artificial proteases toward catalytic drugs for amyloid diseases", J. Neurochem., Vol. 95, pp. 834-847, 2005   DOI   ScienceOn
42 M. P. Lambert, a. K. Barlow, B. A. Chromy, C. Edwards, R. Freed, M. Liosatos, T. E. Morgan, I. Rozovsky, B. Trommer, K. L. Viola, P. Wals, C. Zhang, C. E. Finch, G. A. Krafft, and W. L. Klein, "Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins", Proc. Natl. Acad. Sci. USA, Vol. 95, pp. 6448-6453, 1998.   DOI   ScienceOn
43 M. Bucciantini, E. Giannoni, F. Chiti, F. Baroni, L. Formigli, J. Zurdo, N. Taddei, G. Ramponi, C. M. Dobson, and M. Stefani, "Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases", Nature, Vol. 416, pp. 507-511, 2002.   DOI   ScienceOn
44 S. Lesne, M. T. Koh, L. Kotilinek, R. Kayed, C. G. Glabe, A. Yang, M. Gallagher, and K. H. Ashe, "A specific amyloid-beta protein assembly in the brain impairs memory", Nature, Vol. 440, pp. 352-357, 2006.   DOI   ScienceOn
45 M. A Westerman, D. Cooper-Blacketer, A. Mariash, L. Kotilinek, T. Kawarabayashi, L. H. Younkin, G. A. Carlson, S. G. Younkin, and K. H. Ashe, J. Neurosci., "The relationship between $A{\beta}$ and memory in the Tg2576 mouse model of Alzheimer's disease", Vol. 22, pp. 1858-1867, 2002.
46 H. M. Wisniewski and R. D. Terry, "Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers", Prog. Neuropathol. Vol. 2, pp. 1-26, 1973.
47 J. Hardy and D. J Selkoe, "The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics", Science, Vol. 297, pp. 353-356, 2002.   DOI   ScienceOn
48 L. F. Lue, Y. M. Kuo, A. E. Roher, L. Brachova, Y. Shen, L. Sue, T. Beach, J. H. Kurth, R. E. Rydel, and J. Rogers, "Soluble amyloid $\beta$ peptide concentration as a predictor of synaptic change in Alzheimer's disease", Am. J. Pathol., Vol. 155, pp. 853-862, 1999.   DOI   ScienceOn
49 L. M. Billings, S. Oddo, K. N. Green, J. L. McGaugh, and F. M. Laferla, "Intraneuronal $A{\beta}$ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice", Neuron, Vol. 45, pp. 675-688, 2005.   DOI   ScienceOn
50 C. A. Mclean, R. A. Cherny, F. W. Fraser, S. J. Fuller, M. J. Smith, K. Beyreuther, A. I. Bush, and C. L. Masters, "The redox chemistry of the Alzheimer's disease amyloid $\beta$ peptide", Ann. Neurol., Vol. 46, pp. 860-866, 1999.   DOI
51 S. Baglioni, F. Casamenti, M. Bucciantini, L. M. Luheshi, N. Taddei, F. Chiti, C. M. Dobson, and M. Stefani, "Prefibrillar Amyloid Aggregates Could Be Generic Toxins in Higher Organisms", J. Neurosci., Vol. 26, pp. 8160-8167, 2006.   DOI   ScienceOn
52 C. Haass and D. J. Selkoe, "Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide", Nat. Mol. Cell Biol., Vol. 8, pp. 101-112, 2007.   DOI   ScienceOn
53 D. Burdick, B. Soreghan, M. Kwon, J. Kosmoski, M. Knauer, A. Henschen, J. Yates, C. Cotman, and C. Glabe, "A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state", J. Biol. Chem., Vol. 267, pp. 546-554, 1992.
54 C. Hilbich, B. Kisters-Woike, J. Reed, C. L. Masters, and K. Beyreuther, "The interaction of betaamyloid protein fragment (12-28) with lipid environments", J. Mol. Biol., Vol. 218, pp. 149-163, 1991.   DOI
55 J. D. Harper, S. S. Wong, C. M. Lieber, and P. T. Lansbury, "Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-${\beta}$ protein", Chem. Biol., Vol. 4, pp. 119-125, 1997.   DOI   ScienceOn
56 D. A. Kirschner, C. Abraham, and D. J. Selkoe, "Xray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation", Proc. Natl. Acad. Sci. USA, Vol. 83, pp. 503-507 1986.   DOI
57 R. D. Terry, "The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis", J. Neuropathol. Exp. Neurol., Vol. 55, pp. 1023-1025, 1996.   DOI
58 J. P. Cleary, D. M. Walsh, J. J. Hofmeister, G. M. Shankar, M. A. Kuskowski, D. J. Selkoe, and K. H. Ashe, "Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function", Nat. Neurosci., Vol. 8, pp. 79-84, 2005.   DOI   ScienceOn
59 A. M. Catanzariti, T. A. Soboleva, D.A. Jans, P. G. Board, and R.T. Baker, "An efficient system for high-level expression and easy purification of authentic recombinant proteins", Protein Sci., Vol. 13, pp. 1331-1339, 2004.   DOI   ScienceOn
60 G. Rimon, C. E. Bazenet, K. L. Philpott, and L. L. Rubin, "Increased surface phosphatidylserine is an early marker of neuronal apoptosis", J. Neurosci. Res., Vol. 48, pp. 563-570, 1997.   DOI